STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Inspire Medical Systems (NYSE: INSP), a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team is scheduled to present on Monday, January 13, 2025, at 11:15 a.m. Eastern Time.

The presentation will be available through a live webcast, with replay access remaining available for two weeks afterward in the Event Archive section of Inspire's Investor website at investors.inspiresleep.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-2.03% News Effect

On the day this news was published, INSP declined 2.03%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025.

Inspire is scheduled to present at 11:15 a.m. Eastern Time. The presentation will be accessible via a live webcast here.

Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443


FAQ

When is Inspire Medical Systems (INSP) presenting at the J.P. Morgan Healthcare Conference 2025?

Inspire Medical Systems (INSP) is scheduled to present at the J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 11:15 a.m. Eastern Time.

How can investors watch Inspire Medical Systems' (INSP) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live webcast, and replays will be available for two weeks afterward in the Event Archive section of Inspire's Investor website at investors.inspiresleep.com.

What is the focus of Inspire Medical Systems' (INSP) healthcare technology?

Inspire Medical Systems focuses on developing and commercializing innovative, minimally invasive solutions for patients with obstructive sleep apnea.

How long will the INSP presentation replay be available after the J.P. Morgan Healthcare Conference?

The presentation replay will be available for two weeks following the presentation in the Event Archive section of Inspire's Investor website.
Inspire Medical

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Latest SEC Filings

INSP Stock Data

4.18B
28.71M
1.14%
117.62%
7.94%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GOLDEN VALLEY